研報掘金丨中原證券:中國銀河年度歸母淨利重回百億,維持“增持”評級
中原證券研報指出,中國銀河(601881.SH)24年實現歸母淨利潤100.31億元,同比+27.31%;報告期內公司持續夯實零售客羣基礎,財富管理業務優勢持續鞏固;債權融資規模再創歷史新高,股權融資業務加強項目儲備,投行業務專業化改革成效初顯;投資交易業務收益回報實現大幅增長,對公司業績貢獻顯著;國際業務強化境內外融合發展,差異化的競爭力持續提升。作爲中央匯金控股的券商,公司經營聚焦服務國家重大戰略及實體經濟,未來有望在扶優限劣以及建設一流投資銀行的政策導向中持續受益。維持“增持”的投資評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.